Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleArbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals Aug 03, 2015 Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals 12.1 KB ... Read more Summary ToggleTekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company Jul 20, 2015 Tekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company 23.7 KB ... Read more Summary ToggleTekmira Provides Update on TKM-Ebola-Guinea Jun 19, 2015 Tekmira Provides Update on TKM-Ebola-Guinea 23.8 KB ... Read more Summary ToggleTekmira to Present at JMP Securities Life Sciences Conference Jun 18, 2015 Tekmira to Present at JMP Securities Life Sciences Conference 14.2 KB ... Read more Summary ToggleTekmira to Present at Jefferies 2015 Healthcare Conference May 21, 2015 Tekmira to Present at Jefferies 2015 Healthcare Conference 14.3 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2015 Results May 06, 2015 Tekmira Provides Corporate Update and Announces First Quarter 2015 Results 40.3 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira to Present at Deutsche Bank Health Care Conference May 01, 2015 Tekmira to Present at Deutsche Bank Health Care Conference 14.4 KB ... Read more Summary ToggleTekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal Apr 22, 2015 Tekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal 14.6 KB Findings Validate Adaptability of siRNA-LNP to Rapidly Target Emerging Viral Strains ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results Apr 22, 2015 Tekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results 14.6 KB ... Read more Summary ToggleFDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers Apr 10, 2015 Multiple Dosing Cohort of the Phase I Clinical Study of TKM-Ebola Expected to be Initiated in Q2 ... Read more Pagination First page First Previous page Previous … Page 25 Current page 26 Page 27 Page 28 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleArbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals Aug 03, 2015 Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals 12.1 KB ... Read more Summary ToggleTekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company Jul 20, 2015 Tekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company 23.7 KB ... Read more Summary ToggleTekmira Provides Update on TKM-Ebola-Guinea Jun 19, 2015 Tekmira Provides Update on TKM-Ebola-Guinea 23.8 KB ... Read more Summary ToggleTekmira to Present at JMP Securities Life Sciences Conference Jun 18, 2015 Tekmira to Present at JMP Securities Life Sciences Conference 14.2 KB ... Read more Summary ToggleTekmira to Present at Jefferies 2015 Healthcare Conference May 21, 2015 Tekmira to Present at Jefferies 2015 Healthcare Conference 14.3 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2015 Results May 06, 2015 Tekmira Provides Corporate Update and Announces First Quarter 2015 Results 40.3 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira to Present at Deutsche Bank Health Care Conference May 01, 2015 Tekmira to Present at Deutsche Bank Health Care Conference 14.4 KB ... Read more Summary ToggleTekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal Apr 22, 2015 Tekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal 14.6 KB Findings Validate Adaptability of siRNA-LNP to Rapidly Target Emerging Viral Strains ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results Apr 22, 2015 Tekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results 14.6 KB ... Read more Summary ToggleFDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers Apr 10, 2015 Multiple Dosing Cohort of the Phase I Clinical Study of TKM-Ebola Expected to be Initiated in Q2 ... Read more Pagination First page First Previous page Previous … Page 25 Current page 26 Page 27 Page 28 … Next page Next Last page Last
Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals 12.1 KB
Tekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results 14.6 KB
